Home

NICE approves hep C drugs despite funding concerns

By 2015-07-30T12:36:00

Pills bottle

The National Institute for Health and Care Excellence has recommended the use of three new hepatitis C treatments, describing NHS England’s concerns over their cost as ‘not robust’.

You need to be a subscriber to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All HSJ news by sector, topic & region
  • Breaking News announcements
  • App for mobile and offline reading
  • Comment and Daily Insights newsletters
  • Regional roundup newsletters
  • Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant
  • 10 expert briefings every fortnight (Premium only)

Subscribe

to HSJ

Already a subscriber? Sign into your account here